IP Library Assignment 070854/0469
Patent Assignment
Reel/Frame 070854/0469

Change of Address

Recorded: 2025-04-16 Pages: 4
Assignor
Assignee
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
GSK MEDICINES RESEARCH CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY, UNITED KINGDOM
Covered Properties (56)
TRPV4 Antagonist
Application: 16/302,118 →
Publication: US 2020/0308160
Tricyclic Benzoxaborole Compounds and Uses Thereof
Application: 16/695,253 →
Publication: US 2020/0095266
Compounds
Patent: 7,977,344 →
Application: 12/031,764 →
Publication: US 2009/0131458
Crystalline Forms
Patent: 9,902,694 →
Application: 15/111,068 →
Publication: US 2016/0332967
Chemical Compounds
Application: 15/358,458 →
Publication: US 2017/0073309
Cyclopropylamines as LSD1 Inhibitors
Application: 15/708,270 →
Publication: US 2018/0000805
4-Substituted Benzoxaborole Compounds and Uses Thereof
Application: 15/550,693 →
Publication: US 2018/0044353
Tricyclic Benzoxaborole Compounds and Uses Thereof
Application: 15/792,251 →
Publication: US 2018/0044355
CD38 Inhibitors and Methods of Treatment
Patent: 9,840,496 →
Application: 15/529,120 →
Publication: US 2017/0260164
2,3-Disubstituted 1 -Acyl-4-Amino-1,2,3,4-Tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors
Application: 15/466,925 →
Publication: US 2017/0189401
Synthesis of Benzothiazepines
Patent: 9,834,529 →
Application: 15/500,619 →
Publication: US 2017/0210717
TRPV4 Antagonists
Application: 16/796,989 →
Publication: US 2020/0261411
Compounds Useful in Hiv Therapy
Application: 16/865,678 →
Publication: US 2023/0174534
Tricyclic Benzoxaborole Compounds and Uses Thereof
Application: 16/385,547 →
Publication: US 2019/0241586
TRPV4 Antagonists
Application: 16/334,400 →
Publication: US 2021/0299113
Chemical Compounds
Application: 16/226,763 →
Publication: US 2019/0127326
Synthetic Methods
Application: 16/305,439 →
Publication: US 2020/0325110
Crystalline Forms
Application: 16/792,346 →
Publication: US 2020/0308113
2,3-Disubstituted 1-Acyl-4-Amino-1,2,3,4-Tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors
Application: 16/016,955 →
Publication: US 2018/0303831
Methods for Purifying Antibodies
Application: 15/931,062 →
Publication: US 2020/0277330
2,3-Disubstituted 1-Acyl-4-Amino-1,2,3,4-Tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors
Application: 16/735,956 →
Publication: US 2021/0046073
Biopharmaceutical Compositions and Methods for Pediatric Patients
Application: 16/619,146 →
Publication: US 2020/0157206
Pharmaceutical Compositions of Ribavirin
Application: 15/776,140 →
Publication: US 2021/0315915
4-Substituted Benzoxaborole Compounds and Uses Thereof
Application: 17/018,301 →
Publication: US 2021/0053996
Chemical Compounds
Application: 16/872,949 →
Publication: US 2020/0270210
Crystalline Forms of GSK1278863, Preparation Method and Pharmaceutical Use Thereof
Application: 16/818,368 →
Publication: US 2020/0216399
Crystalline Forms of GSK1278863, Preparation Method and Pharmaceutical Use Thereof
Application: 17/174,006 →
Publication: US 2021/0230124
CRYSTALLINE FORMS OF (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile
Application: 15/893,771 →
Publication: US 2018/0170871
Biopharmaceutical Compositions Comprising Interleukin-5 Antibody
Application: 15/754,768 →
Publication: US 2018/0251539
Cyclopropylamines as LSD1 Inhibitors
Patent: 8,853,408 →
Application: 14/007,035 →
Publication: US 2014/0018393
Chemical Compounds
Patent: 8,957,104 →
Application: 13/941,911 →
Publication: US 2014/0024694
TRPV4 Antagonists
Patent: 9,187,464 →
Application: 14/125,378 →
Publication: US 2014/0121206
Cyclopropylamines as LSD1 Inhibitors
Patent: 9,346,840 →
Application: 14/475,762 →
Publication: US 2014/0371176
Chemical Compounds
Patent: 9,533,948 →
Application: 14/549,034 →
Publication: US 2015/0080449
TRPV4 Antagonists
Application: 16/334,391 →
Publication: US 2019/0216774
2,3-Disubstituted 1 -Acyl-4-Amino-1,2,3,4-Tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors
Patent: 9,637,456 →
Application: 14/770,499 →
Publication: US 2016/0016908
Methods for Purifying Antibodies
Application: 14/775,868 →
Publication: US 2016/0024146
Losmapimod for Use in Treating Glomerular Disease
Patent: 9,707,219 →
Application: 14/903,694 →
Publication: US 2016/0220550
Cyclopropylamines as LSD1 Inhibitors
Patent: 9,795,597 →
Application: 15/095,280 →
Publication: US 2016/0220547
Pyrrolo[3,2-D]Pyrimidine Derivatives as Inducers of Human Interferon
Application: 15/119,772 →
Publication: US 2017/0057963
Biopharmaceutical Compositions
Application: 17/373,223 →
Publication: US 2021/0340246
Biopharmaceutical Compositions
Application: 17/373,412 →
Publication: US 2021/0340247
Biopharmaceutical Compositions
Application: 17/373,537 →
Publication: US 2021/0332125
Biopharmaceutical Compositions
Application: 17/684,907 →
Publication: US 2022/0185878
Biopharmaceutical Compositions and Methods for Pediatric Patients
Application: 17/835,321 →
Publication: US 2022/0380451
Biopharmaceutical Compositions
Application: 17/881,988 →
Publication: US 2022/0380452
2,3-Disubstituted 1-Acyl-4-Amino-1,2,3,4-Tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors
Application: 17/895,273 →
Publication: US 2023/0040299
Formulation Comprising Daprodustat
Application: 18/010,245 →
Publication: US 2023/0225977
Methods for Treating Cholestatic Pruritus
Application: 18/031,899 →
Publication: US 2023/0414634
Crystalline Forms of GSK1278863, Preparation Method and Pharmaceutical Use Thereof
Application: 18/300,501 →
Publication: US 2023/0271927
Forms of Linerixibat
Application: 18/258,572 →
Publication: US 2024/0391885
Daprodustat for Reducing Fatigue in a Subject with Anemia Associated with Chronic Kidney Disease
Application: 18/571,386 →
Novel Manufacturing Method of Daprodustat and Precursors Thereof
Application: 18/570,926 →
Publication: US 2024/0228443
Biopharmaceutical Compositions
Application: 18/650,526 →
Publication: US 2024/0294628
Biopharmaceutical Compositions
Application: 18/650,566 →
Publication: US 2024/0294630
Biopharmaceutical Compositions
Application: 18/650,552 →
Publication: US 2024/0294629
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 1, 2008
From: GLAXO GROUP LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 020888/0164 →
Assignment of Assignor's Interest May 1, 2008
From: LAZARIDES, LINOS; SMITH, STEPHEN ALLAN; STOCKER, RICHARD; THEOBALD, COLIN JACK
To: GLAXO GROUP LIMITED
Reel/Frame 020888/0043 →
Assignment of Assignor's Interest Feb 19, 2013
From: GLAXOSMITHKLINE LLC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 029827/0721 →
Assignment of Assignor's Interest Mar 27, 2017
From: AMANS, DOMINIQUE; ATKINSON, STEPHEN JOHN; HARRISON, LEE ANDREW; HIRST, DAVID JONATHAN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 041750/0602 →
Assignment of Assignor's Interest May 24, 2017
From: CADILLA, RODOLFO; SCHULTE, CHRISTIE; DEATON, DAVID NORMAN; HENKE, BRAD RICHARD
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 042551/0204 →
Assignment of Assignor's Interest Jul 31, 2017
From: MITCHELL, MARK B.; GUO, JIASHENG; LIU, BING; ZHOU, XIAOMING
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 043142/0140 →
Assignment of Assignor's Interest Sep 19, 2017
From: JOHNSON, NEIL W.; KASPAREC, JIRI; MILLER, WILLIAM HENRY; ROUSE, MEAGAN B.
To: GLAXOSMITHKLINE LLC
Reel/Frame 043621/0204 →
Assignment of Assignor's Interest Sep 19, 2017
From: GLAXOSMITHKLINE LLC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 043621/0298 →
Assignment of Assignor's Interest Dec 15, 2017
From: ALEMPARTE-GALLARDO, CARLOS; BARROS-AGUIRRE, DAVID; GIORDANO, ILARIA
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 044410/0839 →
Assignment of Assignor's Interest Dec 15, 2017
From: ALLEY, MICHAEL RICHARD KEVIN (DICKON); HERNANDEZ, VINCENT S.; PLATTNER, JACOB J.; LI, XIANFENG
To: ANACOR PHARMACEUTICALS, INC.
Reel/Frame 044884/0260 →
Assignment of Assignor's Interest Nov 16, 2018
From: STOY, PATRICK; BROOKS, CARL A; YE, GUOSEN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 047521/0254 →
Assignment of Assignor's Interest Nov 29, 2018
From: BARCAN, GREGG; GUO, JIASHENG; MORGAN, CHRISTOPHER W.; ROIBAN, GHEORGHE D.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 047619/0422 →
Assignment of Assignor's Interest Dec 19, 2018
From: TURNBULL, PHILIP STEWART; CADILLA, RODOLFO
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 047817/0269 →
Assignment of Assignor's Interest Mar 20, 2019
From: BRNARDIC, EDWARD J; BROOKS, CARL A.; LAWHORN, BRIAN GRIFFIN; LI, PENG
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 048643/0762 →
Assignment of Assignor's Interest Feb 21, 2020
From: BRNARDIC, EDWARD J.; BROOKS, CARL A.; LAWHORN, BRIAN GRIFFIN; LE, GUOSEN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 051883/0845 →
Corrective Assignment to Correct the Patent Assignment Cover Sheet Fourth Conveying Party's Name Guosen Le Previously Recorded at Reel: 051883 Frame: 0845. Assignor(S) Hereby Confirms the Assignment. Dec 2, 2021
From: BRNARDIC, EDWARD J.; BROOKS, CARL A.; LAWHORN, BRIAN GRIFFIN; YE, GUOSEN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 058296/0668 →
Assignment of Assignor's Interest Nov 14, 2023
From: MILLER, JOHN FRANKLIN; VELTHUISEN, EMILE JOHANN
To: GLAXOSMITHKLINE LLC
Reel/Frame 065551/0022 →
Assignment of Assignor's Interest Nov 14, 2023
From: GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
Reel/Frame 065551/0152 →
Assignment of Assignor's Interest Nov 14, 2023
From: GLAXOSMITHKLINE LLC
To: GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
Reel/Frame 065551/0059 →